All Type of News
C-tri, to file international patent for valienamine production process.
C-Tris Inc., a life science venture company announced on Dec. 21 that the international patent for the production process of the intermediate compound, valienamine, of Voglibose, an anti-diabetic drug, was filed.
...
Pfizer Korea delivered 350 million won of scholarship to medical students.Pfizer Korea delivered 350 million won of scholarship for the medical students on Dec. 20 through the Future Partnership Foundation affiliated to the American Chamber of Commerc...
|
Zydenar, an anti-impotence drug, to launch from Dec. 22.Zydenar, a 4th anti-impotence drug developed in the world by Dong-A, will be launched to the market from Dec. 22, which will be available under the physician's prescriptions at ...
|
Ilyang to file health registration for Ilaprazole in China.
Ilyang is conducting a phase III clinical study on Ilaprazole, a new anti-peptic ulcer drug, in China, and intends to apply its NDA probably around February next year for the market launching in the late 2006 under th...
KFDA to detect illegal substance for impotence.
A odd substance in the imported health functional food claimed as an anti-impotence has been identified by the KFDA.
The KFDA found a odd Viagra-like substance from the imported food supplement product and named it...
SK to sign exclusive license agreement for anti-vomiting drug.
SK Chemical Life Science Division announced to sign an exclusive distribution agreement with Japanese Nissen Kyroin pharmaceutical company for Sinseron (Indisetron Hcl 8mg), an anti-vomiting and nausea drug.
Sins...
Pharm manager 2000 5.0 version to launch in March.
IT Council of Korea Pharmaceutical Association took a meeting on Dec. 18 for the discussion of developing "Pharm Manager 2000, 5.0 version" to launch in March next year.
The new version is a consolidated pharmacy m...
6 year pharmacy curricula system unlikely to promulgate soon.
It is assumed that the revised working rules of the High Education Act covering the 6 year pharmacy school system may not be promulgated before the end of this year.
According to the relevant government authority, ...
KFDA approved clinical trials on adult stem cell therapy.
Sewon Cellontech announced that the KFDA approved their cellular therapy, Ostem, after differentiating stem cells into myeloblasts on Dec. 19, which will be the first commercialized case in the world.
The previous...
10 core technologies for the future Biotech markets presented in seminar.
In the seminar of "Announcement meeting for biotech industry fostering policy" at the KFI conference room on Dec. 19 under the sponsorship of the Ministry of Industry and Energy (MOIE), 10 core technologies were sugge...
